[
  {
    "ts": "2025-09-11T20:06:41+00:00",
    "headline": "AbbVie Stock Breaks Out As Its Cash Cow Lives To Fight Another Day",
    "summary": "AbbVie stock broke out Thursday after the pharma announced it had entered a deal that will stave off generic Rinvoq until April 2037.",
    "url": "https://www.investors.com/news/technology/abbvie-stock-rinvoq-generics-settlement-deal/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "547de764-b99c-3444-b835-4f7ff53017ab",
      "content": {
        "id": "547de764-b99c-3444-b835-4f7ff53017ab",
        "contentType": "STORY",
        "title": "AbbVie Stock Breaks Out As Its Cash Cow Lives To Fight Another Day",
        "description": "",
        "summary": "AbbVie stock broke out Thursday after the pharma announced it had entered a deal that will stave off generic Rinvoq until April 2037.",
        "pubDate": "2025-09-11T20:06:41Z",
        "displayTime": "2025-09-11T20:06:41Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/547de764-b99c-3444-b835-4f7ff53017ab/abbvie-stock-breaks-out-as.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/5f28833afc0a5869fde03794f79126d3",
          "originalWidth": 1000,
          "originalHeight": 563,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/9UQVk_iJ14p3xptXxpLIjQ--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/5f28833afc0a5869fde03794f79126d3.cf.webp",
              "width": 1000,
              "height": 563,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/p50G9HvFMUhCXOFEwvozxw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/5f28833afc0a5869fde03794f79126d3.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/news/technology/abbvie-stock-rinvoq-generics-settlement-deal/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-11T19:17:21+00:00",
    "headline": "AbbVie shares hit record high as key immunology drug set for exclusivity until 2037",
    "summary": "(Reuters) -AbbVie shares rose 4% to a record high on Thursday after the U.S. drugmaker said it expected no generic competition for its blockbuster immunology drug Rinvoq until 2037, a four-year extension, according to some analysts.  Rinvoq, used for the treatment of rheumatoid arthritis and other autoimmune diseases, is AbbVie's second best-selling drug behind Skyrizi.  J.P. Morgan analyst Chris Schott said the extension gives AbbVie \"several more years of runway on one of its key growth drivers\", providing more time to develop its experimental drugs ahead of major loss of exclusivity in the mid-2030s.",
    "url": "https://ca.finance.yahoo.com/news/abbvie-shares-hit-record-high-191721112.html",
    "source": "Reuters",
    "provider": "yfinance",
    "raw": {
      "id": "a65a1cf9-79e2-3c0c-82b0-53c74ae09bc6",
      "content": {
        "id": "a65a1cf9-79e2-3c0c-82b0-53c74ae09bc6",
        "contentType": "STORY",
        "title": "AbbVie shares hit record high as key immunology drug set for exclusivity until 2037",
        "description": "",
        "summary": "(Reuters) -AbbVie shares rose 4% to a record high on Thursday after the U.S. drugmaker said it expected no generic competition for its blockbuster immunology drug Rinvoq until 2037, a four-year extension, according to some analysts.  Rinvoq, used for the treatment of rheumatoid arthritis and other autoimmune diseases, is AbbVie's second best-selling drug behind Skyrizi.  J.P. Morgan analyst Chris Schott said the extension gives AbbVie \"several more years of runway on one of its key growth drivers\", providing more time to develop its experimental drugs ahead of major loss of exclusivity in the mid-2030s.",
        "pubDate": "2025-09-11T19:17:21Z",
        "displayTime": "2025-09-11T19:17:21Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/reuters.com/2b1364ecaf05c28f249e141cbc12401a",
          "originalWidth": 800,
          "originalHeight": 533,
          "caption": "FILE PHOTO: A sign stands outside a Abbvie facility in Cambridge, Massachusetts, U.S., May 20, 2021. REUTERS/Brian Snyder/File Photo",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/n8UtvnzyhzeZD8mxAkqCPg--~B/aD01MzM7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/2b1364ecaf05c28f249e141cbc12401a.cf.webp",
              "width": 800,
              "height": 533,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/47nxw8TJx1Yxagy3KJ5HZg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/2b1364ecaf05c28f249e141cbc12401a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Reuters",
          "url": "https://www.reuters.com/"
        },
        "canonicalUrl": {
          "url": "https://ca.finance.yahoo.com/news/abbvie-shares-hit-record-high-191721112.html",
          "site": "finance",
          "region": "CA",
          "lang": "en-CA"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-shares-hit-record-high-191721112.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-11T17:30:00+00:00",
    "headline": "Warren Buffett wouldn’t worry about cash if he retired with just $1M — here’s why and how to copy his strategy",
    "summary": "Here's how you could copy the Oracle of Omaha in today's market.",
    "url": "https://finance.yahoo.com/news/warren-buffett-wouldn-t-worry-173000008.html",
    "source": "Moneywise",
    "provider": "yfinance",
    "raw": {
      "id": "9a492df7-d012-33c9-9b7e-b8f99bdd7bb2",
      "content": {
        "id": "9a492df7-d012-33c9-9b7e-b8f99bdd7bb2",
        "contentType": "STORY",
        "title": "Warren Buffett wouldn’t worry about cash if he retired with just $1M — here’s why and how to copy his strategy",
        "description": "",
        "summary": "Here's how you could copy the Oracle of Omaha in today's market.",
        "pubDate": "2025-09-11T17:30:00Z",
        "displayTime": "2025-09-11T17:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/moneywise_327/2693414375c72e5d489095e6cd25666a",
          "originalWidth": 728,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/jnXAx5uGz36qiU2p9Tah3Q--~B/aD00MDA7dz03Mjg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/moneywise_327/2693414375c72e5d489095e6cd25666a.cf.webp",
              "width": 728,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/2smV_M_G1wlmxl97iUh6zw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/moneywise_327/2693414375c72e5d489095e6cd25666a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Moneywise",
          "url": "https://moneywise.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/warren-buffett-wouldn-t-worry-173000008.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/warren-buffett-wouldn-t-worry-173000008.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "^SPX"
            },
            {
              "symbol": "XOM"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "TDG"
            },
            {
              "symbol": "COST"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-11T16:45:00+00:00",
    "headline": "SNY's Gene Therapy Candidate for Eye Disease Gets FDA Fast Track Tag",
    "summary": "Sanofi's gene therapy SAR402663 for wet AMD earns FDA fast track status, aiming to speed up development and reduce treatment burden.",
    "url": "https://finance.yahoo.com/news/snys-gene-therapy-candidate-eye-164500631.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "d035bebe-d364-3973-b9d3-52ac9fd8d64d",
      "content": {
        "id": "d035bebe-d364-3973-b9d3-52ac9fd8d64d",
        "contentType": "STORY",
        "title": "SNY's Gene Therapy Candidate for Eye Disease Gets FDA Fast Track Tag",
        "description": "",
        "summary": "Sanofi's gene therapy SAR402663 for wet AMD earns FDA fast track status, aiming to speed up development and reduce treatment burden.",
        "pubDate": "2025-09-11T16:45:00Z",
        "displayTime": "2025-09-11T16:45:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/4c89fa4c828d913dc49739912177a966",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/o4IYsXmA1G0eGuhNw0c16g--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/4c89fa4c828d913dc49739912177a966.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/43AXa9s.CTUHOV5OT2wzjA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/4c89fa4c828d913dc49739912177a966.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/snys-gene-therapy-candidate-eye-164500631.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/snys-gene-therapy-candidate-eye-164500631.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "SAN.PA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-11T16:17:00+00:00",
    "headline": "AbbVie in Settlement With Generic Drugmakers on Rinvoq",
    "summary": "The biopharmaceutical company doesn’t expect U.S. generic entry for the drug before 2037 now that it has settled litigation.",
    "url": "https://www.wsj.com/health/pharma/abbvie-in-settlement-with-generic-drugmakers-on-rinvoq-660ac999?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "0411394e-610d-3f76-b8bc-c1fd63ca223a",
      "content": {
        "id": "0411394e-610d-3f76-b8bc-c1fd63ca223a",
        "contentType": "STORY",
        "title": "AbbVie in Settlement With Generic Drugmakers on Rinvoq",
        "description": "",
        "summary": "The biopharmaceutical company doesn’t expect U.S. generic entry for the drug before 2037 now that it has settled litigation.",
        "pubDate": "2025-09-11T16:17:00Z",
        "displayTime": "2025-09-11T16:17:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/0411394e-610d-3f76-b8bc-c1fd63ca223a/abbvie-in-settlement-with.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/26994dd839a67c0c715df5df622a36c2",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/qwqY7J9sdlXtdD01s3_JnA--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/26994dd839a67c0c715df5df622a36c2.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/QEVbeGs1QxzhhjQNu9fiNw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/26994dd839a67c0c715df5df622a36c2.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/health/pharma/abbvie-in-settlement-with-generic-drugmakers-on-rinvoq-660ac999?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-11T15:50:24+00:00",
    "headline": "Why AbbVie Stock Is Jumping Today",
    "summary": "AbbVie's growth prospects are now more secure thanks to its latest news.",
    "url": "https://www.fool.com/investing/2025/09/11/why-abbvie-stock-is-jumping-today/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "2fe5efdb-0750-34a7-be48-69aa3c7f46ad",
      "content": {
        "id": "2fe5efdb-0750-34a7-be48-69aa3c7f46ad",
        "contentType": "STORY",
        "title": "Why AbbVie Stock Is Jumping Today",
        "description": "",
        "summary": "AbbVie's growth prospects are now more secure thanks to its latest news.",
        "pubDate": "2025-09-11T15:50:24Z",
        "displayTime": "2025-09-11T15:50:24Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/06fdf0814c1e450ef11869bb11c36699",
          "originalWidth": 1400,
          "originalHeight": 933,
          "caption": "People wearing white lab coats, smiling and shaking hands.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/lmkGDjRgJi5HjMPHLfOIew--~B/aD05MzM7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/06fdf0814c1e450ef11869bb11c36699.cf.webp",
              "width": 1400,
              "height": 933,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/k2BdL9mH7XqKYH0J.agY9w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/06fdf0814c1e450ef11869bb11c36699.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/09/11/why-abbvie-stock-is-jumping-today/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/why-abbvie-stock-jumping-today-155024530.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-11T14:27:07+00:00",
    "headline": "AbbVie stock rises after securing patent protection for RINVOQ until 2037",
    "summary": "Investing.com -- AbbVie (NYSE:ABBV) stock rose over 3% after the company announced it has settled litigation with all generic manufacturers that filed applications for generic versions of its RINVOQ medication, securing patent protection until 2037.",
    "url": "https://finance.yahoo.com/news/abbvie-stock-rises-securing-patent-142707645.html",
    "source": "Investing.com",
    "provider": "yfinance",
    "raw": {
      "id": "d8ba2472-a17e-3727-9694-f75e96564c8c",
      "content": {
        "id": "d8ba2472-a17e-3727-9694-f75e96564c8c",
        "contentType": "STORY",
        "title": "AbbVie stock rises after securing patent protection for RINVOQ until 2037",
        "description": "",
        "summary": "Investing.com -- AbbVie (NYSE:ABBV) stock rose over 3% after the company announced it has settled litigation with all generic manufacturers that filed applications for generic versions of its RINVOQ medication, securing patent protection until 2037.",
        "pubDate": "2025-09-11T14:27:07Z",
        "displayTime": "2025-09-11T14:27:07Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Investing.com",
          "url": "https://www.investing.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-stock-rises-securing-patent-142707645.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-stock-rises-securing-patent-142707645.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-11T13:00:05+00:00",
    "headline": "AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It",
    "summary": "Recently, Zacks.com users have been paying close attention to AbbVie (ABBV). This makes it worthwhile to examine what the stock has in store.",
    "url": "https://finance.yahoo.com/news/abbvie-inc-abbv-trending-stock-130005555.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "27fdaf22-ed55-3d35-99bd-cd7e606a29c2",
      "content": {
        "id": "27fdaf22-ed55-3d35-99bd-cd7e606a29c2",
        "contentType": "STORY",
        "title": "AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It",
        "description": "",
        "summary": "Recently, Zacks.com users have been paying close attention to AbbVie (ABBV). This makes it worthwhile to examine what the stock has in store.",
        "pubDate": "2025-09-11T13:00:05Z",
        "displayTime": "2025-09-11T13:00:05Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/2a50596f066181e48e4ae0ad6be00462",
          "originalWidth": 900,
          "originalHeight": 600,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/98CLu2lmSTUpr4OkMLeHwg--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/2a50596f066181e48e4ae0ad6be00462.cf.webp",
              "width": 900,
              "height": 600,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/qpn93q_5cIRTjhBkSx0KNQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/2a50596f066181e48e4ae0ad6be00462.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-inc-abbv-trending-stock-130005555.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-inc-abbv-trending-stock-130005555.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "^SPX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]